BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, January 16, 2026
Home
»
Topics
»
Disease categories and therapies
» Endocrine/metabolic
Endocrine/metabolic
RSS
Novel site of action for chimeric insulin-releasing peptide
June 12, 1997
BRL-48482 has potential for reducing cardiovascular risk in NIDDM
June 12, 1997
Phase III results for AY-4166
June 12, 1997
Pioglitazone improves insulin resistance in NIDDM
June 12, 1997
New preclinical studies on JTT-501
June 12, 1997
Clinical results in NIDDM reported for troglitazone
June 12, 1997
Efficacy of pioglitazone demonstrated in NIDDM patients
June 11, 1997
Miglitol tested in specific population subgroups
June 11, 1997
Clinical results reported for Novo Nordisk insulinotropic agent
June 11, 1997
NN-304, a long-acting insulin analogue in preclinical testing
June 10, 1997
Previous
1
2
…
1760
1761
1762
1763
1764
1765
1766
1767
1768
…
1840
1841
Next